Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review
2024

Advancements in Nanoparticle Vaccines for Japanese Encephalitis

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Adugna Takele, Niu Qingli, Guan Guiquan, Du Junzheng, Yang Jifei, Tian Zhancheng, Yin Hong

Primary Institution: State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China

Hypothesis

Can nanoparticle-based vaccines provide effective protection against Japanese encephalitis virus?

Conclusion

Nanoparticle-based vaccines show promise in eliciting strong immune responses and providing effective protection against Japanese encephalitis virus.

Supporting Evidence

  • 28 studies were reviewed, focusing on nanoparticle vaccines for Japanese encephalitis.
  • 57.14% of the studies concentrated on virus-like particles (VLPs).
  • Candidate NP vaccines provided 70–100% protection for immunized mice against lethal challenges.
  • Nanoparticle vaccines can enhance both humoral and cellular immune responses.

Takeaway

Scientists are working on new vaccines for Japanese encephalitis using tiny particles that help the body fight the virus better.

Methodology

A systematic review of 28 studies on nanoparticle-based vaccines for Japanese encephalitis published between 2000 and 2023.

Limitations

The studies varied in quality and methodology, which may affect the comparability of results.

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1505612

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication